Overview
Sandhoff disease, juvenile form, is a rare inherited condition that belongs to a group of disorders called GM2 gangliosidoses. It is also sometimes referred to as juvenile-onset Sandhoff disease or GM2 gangliosidosis type II, juvenile form. In this disease, the body cannot properly break down certain fatty substances called gangliosides in the brain and nerve cells because of a shortage of an enzyme called beta-hexosaminidase. Both the A and B forms of this enzyme are affected due to mutations in the HEXB gene. When these fatty substances build up, they damage nerve cells over time, leading to progressive neurological problems. Symptoms of the juvenile form typically begin between ages 2 and 10, which is later than the more severe infantile form. Children may first show problems with coordination, difficulty walking, speech difficulties, and learning problems. Over time, muscle weakness, vision loss, and intellectual decline can develop. Some children may also experience seizures. The disease is progressive, meaning symptoms worsen over time. Currently, there is no cure for juvenile Sandhoff disease. Treatment focuses on managing symptoms and maintaining quality of life. Researchers are actively studying potential therapies including gene therapy, enzyme replacement therapy, and substrate reduction therapy, but none are yet approved for this condition. Supportive care from a team of specialists is essential to help manage the various symptoms and complications that arise as the disease progresses.
Also known as:
Key symptoms:
Difficulty with coordination and balance (ataxia)Muscle weaknessDifficulty walking or loss of ability to walkSpeech problems or loss of speechLearning difficulties and intellectual declineSeizuresVision lossDifficulty swallowingBehavioral changesSpasticity (stiff muscles)Loss of previously learned skillsTremorsEnlarged liver or spleen in some cases
Clinical phenotype terms (26)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Juvenile
Begins in the teen years
Treatments
No FDA-approved treatments are currently listed for Sandhoff disease, juvenile form.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Sandhoff disease, juvenile form at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Sandhoff disease, juvenile form.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Sandhoff disease, juvenile form.
Community
No community posts yet. Be the first to share your experience with Sandhoff disease, juvenile form.
Start the conversation →Latest news about Sandhoff disease, juvenile form
No recent news articles for Sandhoff disease, juvenile form.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage of the disease is my child currently in, and what changes should we expect next?,Are there any clinical trials or experimental treatments that my child might be eligible for?,What is the best seizure management plan, and when should we go to the emergency room for a seizure?,How can we best support my child's nutrition and swallowing safety as the disease progresses?,What therapies (physical, occupational, speech) do you recommend, and how often?,Should our other children or family members be tested to see if they are carriers?,What palliative care and support services are available for our family?
Common questions about Sandhoff disease, juvenile form
What is Sandhoff disease, juvenile form?
Sandhoff disease, juvenile form, is a rare inherited condition that belongs to a group of disorders called GM2 gangliosidoses. It is also sometimes referred to as juvenile-onset Sandhoff disease or GM2 gangliosidosis type II, juvenile form. In this disease, the body cannot properly break down certain fatty substances called gangliosides in the brain and nerve cells because of a shortage of an enzyme called beta-hexosaminidase. Both the A and B forms of this enzyme are affected due to mutations in the HEXB gene. When these fatty substances build up, they damage nerve cells over time, leading to
How is Sandhoff disease, juvenile form inherited?
Sandhoff disease, juvenile form follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Sandhoff disease, juvenile form typically begin?
Typical onset of Sandhoff disease, juvenile form is juvenile. Age of onset can vary across affected individuals.